Prescribing Update

View in web browser | Add to safe senders

Prescribing Update

4th December 2023

MIMS dermatology supplement available online

4 December 2023, 10:00am

Read the latest digital MIMS+ supplement for free now.

Valproate prescribing: plan for new regulatory measures without delay, instructs MHRA

29 November 2023, 8:52am

A National Patient Safety Alert (NatPSA) has been issued asking organisations to put in place a plan to implement new regulatory measures for valproate prescribing by the end of January 2024.

Alternate-day iron dosing in women 'effective and better tolerated'

28 November 2023, 10:14am

In iron-depleted women, alternate-day iron supplementation had comparable efficacy to and triggered fewer gastrointestinal side-effects than consecutive-day dosing, a randomised controlled study has found.

New resource for ADHD prescribing

22 November 2023, 3:18pm

MIMS tool highlights available prescribing options.

Recently updated

Hormone replacement therapy (HRT) 22 November 2023, 9:58am Hormone doses and costs of HRT preparations.

Attention Deficit Hyperactivity Disorder (ADHD) Treatments 21 November 2023, 9:28am NEW \| Licensed ADHD formulations and their place in therapy.

Ophthalmic preparations, preservatives and potential sensitisers as ingredients 14 November 2023, 7:00am Potential sensitising agents in eye drops and ointments.

Drug shortages tracker

Drug shortages - live tracker

4 December 2023, 7:21am

EXCLUSIVE TO SUBSCRIBERS Use our constantly updated shortages tracker to check on drugs in short supply. Updated 4th December: added Ezetrol, ezetimibe 10mg tab (Accord).